{
  "id": 3485082,
  "title": "Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use",
  "url": "https://urgent.news/2026/08/26/cronus-pharma-launches-first-fda-approved-bioequivalent-robenacoxib",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-26T10:03:11.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/cronus-pharma-launches-first-fda-approved-bioequivalent-robenacoxib-injection-for-veterinary-use"
  },
  "original_language": "en",
  "account": null,
  "summary": "First bioequivalent to ONSIOR® (robenacoxib) Injection equips veterinarians with new, cost-effective NSAID (nonsteroidal anti-inflammatory) option for controlling postoperative pain and inflammation with certain surgical procedures in dogs and cats. EAST BRUNSWICK, N.J. — Cronus Pharma LLC, a veterinary pharmaceutical company focused on developing high-quality, cost-effective animal health…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}